P.110 Entecavir is well tolerated for the treatment of nucleoside-naive and lamivudine-refractory chronic hepatitis B: phase II/III safety results

✍ Scribed by M. Raptopoulou Gigi; M. Manns; E. Cooney; R. Hindes; A. Cross; R. Wilber

• Book ID: 117770332
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 141 KB
• Volume: 36
• Category: Article
• ISSN: 1386-6532
• DOI: 10.1016/s1386-6532(06)80292-1